B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1

被引:130
作者
Shu, HB
Johnson, H
机构
[1] Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA
[2] Univ Colorado, Sch Med, Denver, CO 80206 USA
[3] Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China
关键词
D O I
10.1073/pnas.160213497
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
TALL-1 is a recently identified member of the tumor necrosis factor (TNF) family that costimulates B lymphocyte proliferation. Here we show that B cell maturation protein (BCMA), a member of the TNF receptor family that is expressed only by B lymphocytes, specifically binds to TALL-1. A soluble receptor containing the extracellular domain of BCMA blocks the binding of TALL-1 to its receptor on the plasma membrane and inhibits TALL-1-triggered B lymphocyte costimulation. Overexpression of BCMA activates NF-kappa B, and this activation is potentiated by TALL-1. Moreover, BCMA-mediated NF-kappa B activation is inhibited by dominant negative mutants of TNF receptor-associated factor 5 (TRAF5), TRAF6, NF-kappa B-inducing kinase (NIK), and I kappa B kinase (IKK). These data indicate that BCMA is a receptor for TALL-1 and BCMA activates NF-kappa B through a TRAF5-, TRAF6-, NIK-, and IKK-dependent pathway. The identification of BCMA as a NF-kappa B-activating receptor for TALL-1 suggests molecular targets for drug development against certain immunodeficient or autoimmune diseases.
引用
收藏
页码:9156 / 9161
页数:6
相关论文
共 30 条
  • [1] A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
    Anderson, DM
    Maraskovsky, E
    Billingsley, WL
    Dougall, WC
    Tometsko, ME
    Roux, ER
    Teepe, MC
    DuBose, RF
    Cosman, D
    Galibert, L
    [J]. NATURE, 1997, 390 (6656) : 175 - 179
  • [2] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [3] Modulation of life and death by the TNF receptor superfamily
    Baker, SJ
    Reddy, EP
    [J]. ONCOGENE, 1998, 17 (25) : 3261 - 3270
  • [4] Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
    Bennett, M
    Macdonald, K
    Chan, SW
    Luzio, JP
    Simari, R
    Weissberg, P
    [J]. SCIENCE, 1998, 282 (5387) : 290 - 293
  • [5] TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
    Chicheportiche, Y
    Bourdon, PR
    Xu, HD
    Hsu, YM
    Scott, H
    Hession, C
    Garcia, I
    Browning, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32401 - 32410
  • [6] Phosphorylation of tumor necrosis factor receptor CD120a (p55) by p42mapk/erk2 induces changes in its subcellular localization
    Cottin, V
    Van Linden, A
    Riches, DWH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) : 32975 - 32987
  • [7] The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
    Degli-Esposti, MA
    Dougall, WC
    Smolak, PJ
    Waugh, JY
    Smith, CA
    Goodwin, RG
    [J]. IMMUNITY, 1997, 7 (06) : 813 - 820
  • [8] BCMAP - AN INTEGRAL MEMBRANE-PROTEIN IN THE GOLGI-APPARATUS OF HUMAN MATURE B-LYMPHOCYTES
    GRAS, MP
    LAABI, Y
    LINARESCRUZ, G
    BLONDEL, MO
    RIGAUT, JP
    BROUET, JC
    LECA, G
    HAGUENAUERTSAPIS, R
    TSAPIS, A
    [J]. INTERNATIONAL IMMUNOLOGY, 1995, 7 (07) : 1093 - 1106
  • [9] Grewal IS, 1996, IMMUNE TOLERANCE, P125
  • [10] TRAIL: a molecule with multiple receptors and control mechanisms
    Griffith, TS
    Lynch, DH
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 559 - 563